{
    "matches": [
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "381",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[381, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "114",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[114, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.9]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "43",
                    "percentage": "11"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[43, 11]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "382",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[382, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "115",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[115, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "73",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[73, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "44",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[44, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "26",
                    "percentage": "7"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[26, 7]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "as-randomized",
                    "total_participants": "382",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "17",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[17, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "HIV VL",
                    "participants": "330",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[330, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "HIV VL",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "HIV VL",
                    "participants": "65",
                    "percentage": "20"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[65, 20]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "HIV VL",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[11.8]"
            },
            "match": "yes"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "HIV VL",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "HIV VL",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "HIV detection visit",
                    "measure": "CD4",
                    "participants": "331",
                    "percentage": "100"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[331, 100]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M3",
                    "measure": "CD4",
                    "participants": "99",
                    "percentage": "30"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[99, 30]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M6",
                    "measure": "CD4",
                    "participants": "64",
                    "percentage": "19"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[64, 19]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M9",
                    "measure": "CD4",
                    "participants": "40",
                    "percentage": "12"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[40, 12]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M12",
                    "measure": "CD4",
                    "participants": "25",
                    "percentage": "8"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[25, 8]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "133",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "135",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[36.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "HIV detection visit": "114",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[39.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[19.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[17.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.2]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "As-randomized",
                    "sample size": 382,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[13.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "106",
                    "method": "DMPA-IM",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[23.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "118",
                    "method": "Copper IUD",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[34.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "HIV detection visit": "107",
                    "method": "LNG implant",
                    "month": "M3"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[41.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[9.3]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M6"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[18.1]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.8]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M9"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.5]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[2.4]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[6.9]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M12"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[15.6]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "DMPA-IM",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[7.7]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "Copper IUD",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[10.0]"
            },
            "match": "no"
        },
        {
            "Extracted_claim": {
                "subject": {
                    "analysis_group": "continuous use",
                    "total_participants": "331",
                    "excluded_participants": "women infected at baseline and visits following ART initiation",
                    "timepoint": "M15",
                    "measure": "CD4",
                    "participants": "14",
                    "percentage": "4"
                },
                "measures": "[participants, percentage]",
                "outcomes": "[14, 4]"
            },
            "Ground_truth_claim": {
                "subject": {
                    "summary": "HIV Seroconverter Data",
                    "timepoint": "HIV detection visit",
                    "group": "Consistent-use",
                    "sample size": 331,
                    "method": "LNG implant",
                    "month": "M15"
                },
                "measures": "[Attended visit %]",
                "outcomes": "[14.3]"
            },
            "match": "no"
        }
    ],
    "total_extracted_claims": 24,
    "total_ground_truth_claims": 30,
    "number_of_matches": 2
}